vs
Side-by-side financial comparison of Barnes & Noble Education, Inc. (BNED) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Barnes & Noble Education, Inc. is the larger business by last-quarter revenue ($598.2M vs $493.8M, roughly 1.2× Pediatrix Medical Group, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 4.2%, a 2.6% gap on every dollar of revenue. On growth, Barnes & Noble Education, Inc. posted the faster year-over-year revenue change (6.9% vs -1.7%). Over the past eight quarters, Barnes & Noble Education, Inc.'s revenue compounded faster (20.0% CAGR vs -0.1%).
Barnes & Noble Booksellers is an American bookseller with the largest number of retail outlets in the United States. The company operates approximately 700+ retail stores across the United States.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
BNED vs MD — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $598.2M | $493.8M |
| Net Profit | $25.0M | $33.7M |
| Gross Margin | 21.7% | — |
| Operating Margin | 6.8% | 9.9% |
| Net Margin | 4.2% | 6.8% |
| Revenue YoY | 6.9% | -1.7% |
| Net Profit YoY | -49.7% | 10.5% |
| EPS (diluted) | $0.72 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $598.2M | $493.8M | ||
| Q3 25 | $274.2M | $492.9M | ||
| Q2 25 | $233.0M | $468.8M | ||
| Q1 25 | $419.7M | $458.4M | ||
| Q4 24 | $559.7M | $502.4M | ||
| Q3 24 | $250.9M | $511.2M | ||
| Q2 24 | $192.7M | $504.3M | ||
| Q1 24 | $415.4M | $495.1M |
| Q4 25 | $25.0M | $33.7M | ||
| Q3 25 | $-18.3M | $71.7M | ||
| Q2 25 | $-23.0M | $39.3M | ||
| Q1 25 | $17.9M | $20.7M | ||
| Q4 24 | $43.2M | $30.5M | ||
| Q3 24 | $-103.9M | $19.4M | ||
| Q2 24 | $-41.9M | $-153.0M | ||
| Q1 24 | $-9.3M | $4.0M |
| Q4 25 | 21.7% | — | ||
| Q3 25 | 20.2% | — | ||
| Q2 25 | 30.3% | — | ||
| Q1 25 | 22.3% | — | ||
| Q4 24 | 23.0% | — | ||
| Q3 24 | 17.9% | — | ||
| Q2 24 | 28.7% | — | ||
| Q1 24 | 24.2% | — |
| Q4 25 | 6.8% | 9.9% | ||
| Q3 25 | -8.4% | 13.8% | ||
| Q2 25 | -4.9% | 12.8% | ||
| Q1 25 | 4.5% | 7.0% | ||
| Q4 24 | 8.4% | 7.8% | ||
| Q3 24 | -15.4% | 6.6% | ||
| Q2 24 | -16.3% | -31.3% | ||
| Q1 24 | 0.4% | 3.2% |
| Q4 25 | 4.2% | 6.8% | ||
| Q3 25 | -6.7% | 14.5% | ||
| Q2 25 | -9.9% | 8.4% | ||
| Q1 25 | 4.3% | 4.5% | ||
| Q4 24 | 7.7% | 6.1% | ||
| Q3 24 | -41.4% | 3.8% | ||
| Q2 24 | -21.7% | -30.3% | ||
| Q1 24 | -2.2% | 0.8% |
| Q4 25 | $0.72 | $0.40 | ||
| Q3 25 | $-0.54 | $0.84 | ||
| Q2 25 | $2.97 | $0.46 | ||
| Q1 25 | $0.59 | $0.24 | ||
| Q4 24 | $1.63 | $0.37 | ||
| Q3 24 | $-7.69 | $0.23 | ||
| Q2 24 | $-15.68 | $-1.84 | ||
| Q1 24 | $-3.49 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $11.7M | $375.2M |
| Total DebtLower is stronger | $122.5M | $570.5M |
| Stockholders' EquityBook value | $283.2M | $865.9M |
| Total Assets | $1.1B | $2.2B |
| Debt / EquityLower = less leverage | 0.43× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.7M | $375.2M | ||
| Q3 25 | $7.3M | $340.1M | ||
| Q2 25 | $9.1M | $224.7M | ||
| Q1 25 | $9.2M | $99.0M | ||
| Q4 24 | $11.6M | $229.9M | ||
| Q3 24 | $8.2M | $103.8M | ||
| Q2 24 | $10.5M | $19.4M | ||
| Q1 24 | $8.1M | $8.0M |
| Q4 25 | $122.5M | $570.5M | ||
| Q3 25 | $170.0M | $577.2M | ||
| Q2 25 | $103.1M | $583.9M | ||
| Q1 25 | $141.2M | $590.5M | ||
| Q4 24 | $177.6M | $597.1M | ||
| Q3 24 | $221.9M | — | ||
| Q2 24 | $196.3M | — | ||
| Q1 24 | $30.2M | — |
| Q4 25 | $283.2M | $865.9M | ||
| Q3 25 | $256.5M | $890.7M | ||
| Q2 25 | $272.2M | $833.8M | ||
| Q1 25 | $292.9M | $789.2M | ||
| Q4 24 | $211.4M | $764.9M | ||
| Q3 24 | $149.8M | $732.5M | ||
| Q2 24 | $80.4M | $706.5M | ||
| Q1 24 | $121.5M | $856.2M |
| Q4 25 | $1.1B | $2.2B | ||
| Q3 25 | $950.8M | $2.2B | ||
| Q2 25 | $790.3M | $2.1B | ||
| Q1 25 | $1.1B | $2.0B | ||
| Q4 24 | $1.0B | $2.2B | ||
| Q3 24 | $973.2M | $2.1B | ||
| Q2 24 | $909.9M | $2.0B | ||
| Q1 24 | $1.2B | $2.2B |
| Q4 25 | 0.43× | 0.66× | ||
| Q3 25 | 0.66× | 0.65× | ||
| Q2 25 | 0.38× | 0.70× | ||
| Q1 25 | 0.48× | 0.75× | ||
| Q4 24 | 0.84× | 0.78× | ||
| Q3 24 | 1.48× | — | ||
| Q2 24 | 2.44× | — | ||
| Q1 24 | 0.25× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $66.2M | $114.1M |
| Free Cash FlowOCF − Capex | $61.9M | — |
| FCF MarginFCF / Revenue | 10.4% | — |
| Capex IntensityCapex / Revenue | 0.7% | — |
| Cash ConversionOCF / Net Profit | 2.65× | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $-4.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $66.2M | $114.1M | ||
| Q3 25 | $-67.6M | $137.3M | ||
| Q2 25 | $52.6M | $137.2M | ||
| Q1 25 | $-41.9M | $-117.5M | ||
| Q4 24 | $47.4M | $133.0M | ||
| Q3 24 | $-143.5M | $91.8M | ||
| Q2 24 | $81.7M | $107.0M | ||
| Q1 24 | $-35.8M | $-125.2M |
| Q4 25 | $61.9M | — | ||
| Q3 25 | $-71.3M | — | ||
| Q2 25 | $49.5M | — | ||
| Q1 25 | $-44.7M | — | ||
| Q4 24 | $44.4M | — | ||
| Q3 24 | $-147.5M | — | ||
| Q2 24 | $79.1M | — | ||
| Q1 24 | $-39.0M | — |
| Q4 25 | 10.4% | — | ||
| Q3 25 | -26.0% | — | ||
| Q2 25 | 21.3% | — | ||
| Q1 25 | -10.7% | — | ||
| Q4 24 | 7.9% | — | ||
| Q3 24 | -58.8% | — | ||
| Q2 24 | 41.1% | — | ||
| Q1 24 | -9.4% | — |
| Q4 25 | 0.7% | — | ||
| Q3 25 | 1.4% | — | ||
| Q2 25 | 1.3% | — | ||
| Q1 25 | 0.7% | — | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 1.6% | — | ||
| Q2 24 | 1.4% | — | ||
| Q1 24 | 0.8% | — |
| Q4 25 | 2.65× | 3.39× | ||
| Q3 25 | — | 1.91× | ||
| Q2 25 | — | 3.49× | ||
| Q1 25 | -2.34× | -5.66× | ||
| Q4 24 | 1.10× | 4.36× | ||
| Q3 24 | — | 4.72× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BNED
| Course Materials Product | $459.3M | 77% |
| General Merchandise Product | $112.9M | 19% |
| Serviceand Other | $26.1M | 4% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
